長江生命科技(00775.HK)就對COVID-19測試需求訂立許可協議
格隆匯3月27日丨長江生命科技(00775.HK)公告,公司全資附屬公司CKLife Sciences Development Limited已與新加坡科技研究院旗下附屬公司訂立許可協議,以在香港以至全球製造、分銷、推銷及出售以CoV-2冠狀病毒(SARS-CoV-2)逆轉錄聚合酶鏈式反應進行COVID-19測試的檢測試劑盒。
檢測試劑盒專為檢測SARS-CoV-2RNA病毒蹤影而設計,可為檢測提供高度的敏感度及準確性,且並無顯示與SARS-CoV、中東呼吸綜合症(MERS-CoV)及流感等密切相關的呼吸道病毒出現任何交叉反應。
該檢測試劑盒由A*Star及陳篤生醫院(TanTockSengHospital)共同研發,並已取得新加坡衞生科學局(HealthSciencesAuthority)臨時認可於新加坡使用。自2020年二月以來,該檢測試劑盒已獲新加坡當地六家公立醫院及一傢俬立醫療集團採用。
公司相信,該檢測試劑盒是一項適時選擇,有助加快對香港趨增懷疑COVID-19個案進行檢測。此檢測試劑盒已獲新加坡醫院採用,為一項可即時應用的認可技術,測試結果可於二至四小時內提供。該檢測試劑盒亦令更多醫療機構及實驗室可進行測試,從而令患者得以迅速隔離及接受治療。
公司已向聯交所申請公司股份自2020年3月30日上午九時正起恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.